Literature DB >> 22038358

Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells.

Hongkuan Yang1, Feng Mao1, Huaqiu Zhang1, Baofeng Wang2, Feng Wan1, Dongsheng Guo1, Ting Lei1.   

Abstract

This study examined the effects of over-expression of leucine-rich repeats and immunoglobulin-like domains 3 (LRIG3) on the cell cycle and survival of human glioma cell line U87 and U251 and explored the possible mechanisms. The LRIG3 gene was transduced into U87 and U251 cells respectively by using lentivirus and the transduced cells were selected by puromycin. The changes in LRIG3 mRNA and protein levels were measured by RT-PCR and Western blotting. The apoptosis rate was detected by Annexin V-FITC/PI double labeling and the cell cycle was flow cytometrically analyzed. Compared with control cells, LRIG3 mRNA expression in U251 and U87 cells transduced with pLVX-DsRed-LRIG3-Monomer-N1 were increased by 77.6% and 129.7%, and LRIG3 protein expression was raised by 141.3% and 322.7%, respectively. Cell cycle analysis showed that LRIG3 over-expression increased the percentage of cells at G(0)/G(1) phase (P<0.01). Over-expressed LRIG3 could significantly promote the apoptosis of U87 and U251 cells (P<0.05). These findings suggest that the over-expression of LRIG3 could arrest the cell cycle in G(0)/G(1) phase, and promote apoptosis of U87 and U251 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22038358     DOI: 10.1007/s11596-011-0579-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

Review 1.  Lentivirus vectors: difficulties and hopes before clinical trials.

Authors:  T Kafri
Journal:  Curr Opin Mol Ther       Date:  2001-08

2.  The choice of a suitable lentivirus vector: transcriptional targeting.

Authors:  Francesco Lotti; Fulvio Mavilio
Journal:  Methods Mol Biol       Date:  2003

3.  Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.

Authors:  Mingjun Cai; Ruifan Xie; Lin Han; Rudong Chen; Baofeng Wang; Fei Ye; Dongsheng Guo; Ting Lei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

4.  Cloning, characterization, and expression of human LIG1.

Authors:  J Nilsson; C Vallbo; D Guo; I Golovleva; B Hallberg; R Henriksson; H Hedman
Journal:  Biochem Biophys Res Commun       Date:  2001-06-29       Impact factor: 3.575

5.  Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways.

Authors:  Hui Zhao; Kosuke Tanegashima; Hyunju Ro; Igor B Dawid
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

6.  Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.

Authors:  Dongsheng Guo; Jonas Nilsson; Hannu Haapasalo; Olayinka Raheem; Tommy Bergenheim; Håkan Hedman; Roger Henriksson
Journal:  Acta Neuropathol       Date:  2006-03-11       Impact factor: 17.088

7.  Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.

Authors:  W Yi; H Haapasalo; C Holmlund; S Järvelä; O Raheem; A T Bergenheim; Håkan Hedman; R Henriksson
Journal:  Clin Neuropathol       Date:  2009 Jan-Feb       Impact factor: 1.368

8.  Characterization and tissue-specific expression of human LRIG2.

Authors:  Camilla Holmlund; Jonas Nilsson; Dongsheng Guo; Anna Starefeldt; Irina Golovleva; Roger Henriksson; Håkan Hedman
Journal:  Gene       Date:  2004-05-12       Impact factor: 3.688

9.  Restriction of lentivirus in monkeys.

Authors:  Caroline Besnier; Yasuhiro Takeuchi; Greg Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

10.  Cross-repressive interactions between Lrig3 and netrin 1 shape the architecture of the inner ear.

Authors:  Victoria E Abraira; Tony Del Rio; Andrew F Tucker; John Slonimsky; Hannah L Keirnes; Lisa V Goodrich
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

View more
  2 in total

1.  Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.

Authors:  Qungen Xiao; Yihu Tan; Yang Guo; Hongkuan Yang; Feng Mao; Ruifan Xie; Baofeng Wang; Ting Lei; Dongsheng Guo
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

2.  LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma.

Authors:  Chenghao Peng; Hanmin Chen; Youwei Li; Hang Yang; Peizhong Qin; Baojun Ma; Qiuhong Duan; Baofeng Wang; Feng Mao; Dongsheng Guo
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.